Beeline Medicines
The Executive Director, Regulatory Affairs at Beeline Medicines will serve as the global regulatory lead, shaping and executing regulatory strategies for assigned programs worldwide. Reporting to the Senior Vice President, Regulatory Affairs & Quality, the role oversees IND, CTA, NDA, MAA submissions, lifecycle management, and coordination with health authorities, while managing contractors and future direct reports in a hybrid work environment.
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies that target the drivers of immune dysfunction. The company is advancing a pipeline of therapies for autoimmune and inflammatory diseases, including its lead program afimetoran, a TLR7/8 inhibitor in late-stage clinical development for lupus. Beeline Medicines aims to define new treatment paradigms for patients living with chronic immune-mediated conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beeline Medicines.
32% above the average for this role
Senior Manager, Regulatory Affairs
Transforming Hypertrophic Cardiomyopathy Care
Senior Director, Global Regulatory Affairs
Jobgether
Vice President, Regulatory Affairs
Prime Medicine
Senior Manager, Regulatory Affairs
Nuvalent, Inc.
Vice President, Regulatory Affairs
Clinical Dynamix
Director, Regulatory Affairs, Europe
Revolution Medicines